Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Effect of virtual reality-based balance training in multiple sclerosis.
Melanoma complicating treatment with natalizumab for multiple sclerosis.
Chronic cerebrospinal venous insufficiency and venous stenoses in multiple sclerosis.
Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models.
Cognitive dysfunction in multiple sclerosis.
Interventions to evaluate fitness to drive among people with chronic conditions: Systematic review of literature.
Scoring treatment response in patients with relapsing multiple sclerosis.
Y-39983, a Selective Rho-Kinase Inhibitor, Attenuates Experimental Autoimmune Encephalomyelitis via Inhibition of Demyelination.
Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study.
4-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer.
Diffusion tensor imaging of the cervical spinal cord of patients with Neuromyelitis Optica.
JC virus urinary excretion and seroprevalence in natalizumab-treated multiple sclerosis patients.
Immune-Reconstitution Inflammatory Syndrome in Multiple Sclerosis Patients Treated With Natalizumab: A Series of 4 Cases.
Detrimental role of granulocyte-colony stimulating factor in neuromyelitis optica: clinical case and histological evidence.
Multiple sclerosis: Phases of disease improvement unrelated to relapses.
Interleukin-2 and the brain: dissecting central versus peripheral contributions using unique mouse models.
Neutralizing Antibodies Are Associated with a Reduction of Interferon-β Efficacy during the Treatment of Japanese Multiple Sclerosis Patients.
Unilateral ankle dorsiflexor spasticity: an uncommon, disabling complication of transverse myelitis.
Recombinant Expression of Margatoxin and Agitoxin-2 in Pichia pastoris: An Efficient Method for Production of K(V)1.3 Channel Blockers.
Interaction between HLA-DRB1-DQB1 Haplotypes in Sardinian Multiple Sclerosis Population.
Unemployment in multiple sclerosis (MS): utility of the MS Functional Composite and cognitive testing.
Clinical and pathological effects of intrathecal injection of mesenchymal stem cell-derived neural progenitors in an experimental model of multiple sclerosis.
Do people with and without medical conditions respond similarly to the Short Health Anxiety Inventory? An assessment of differential item functioning using item response theory.
Progressive multiple sclerosis and mood disorders.
The CSF JCV antibody index for diagnosis of natalizumab-associated PML.
Pages
« first
‹ previous
…
205
206
207
208
209
210
211
212
213
…
next ›
last »